PMID: 42173109

Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial.

Helsted Mads M, Fonnesbech-Wulff Christiane, Schaltz Nina L, Lund Ingrid W, Forman Julie L, Nielsen Casper K, Englund Anders, Hartmann Bolette, Vilsbøll Tina, Holst Jens J

The lancet. Diabetes & endocrinology · 2026

This entry links to third-party literature. For research use only.